Pre- and post-stroke oral antithrombotics and mortality in patients with ischaemic stroke.

ABSTRACT:

Background

Reducing stroke occurrence requires the effective management of cardiovascular and other stroke risk factors.

Purpose

To describe pre- and post-stroke medication use, focusing on antithrombotic therapy and mortality risk, in individuals hospitalised for ischaemic stroke (IS) in the United Kingdom.

Method

Using primary care electronic health records from the United Kingdom, we identified patients hospitalised for IS (July 2016-September 2019) and classed them into three groups: atrial fibrillation (AF) diagnosed pre-stroke, AF diagnosed post-stroke, and non-AF stroke (no AF diagnosed pre-/post-stroke). We determined use of cardiovascular medications in the 90 days pre- and post-stroke and calculated mortality rates.

Results

There were 3201 hospitalise

SUBMITTER: Garcia Rodriguez LA 

PROVIDER: S-EPMC9825966 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature